anthonyyazdaniml/gliner-biomed-balanced-curated-corpus huggingface dataset:
&lt;P&gt;PROBLEM TO BE SOLVED: To conduct electrocardiographic data display and on-screen measurement.  &lt;P&gt;SOLUTION: A user inputting device 202 includes a key board and mouse, joy stick, touch pad, and touch screen. An interactive display engine 204 is constituted so as to display time-series data such as electrocardiographic (ECG) data etc., as a graph on a display device 206. The interactive display sufficiently utilizes pattern recognition skill cultivated by internists through training and long-year experience by displaying ECG data in a form of emulating a standard type of recording on paper. The time-series medical data source 208 can be directly obtained from a digitized ECG data stored in a computer file and an ECG device which can supply digital output.  &lt;P&gt;COPYRIGHT: (C)2004,JPO
Systems and methods for processing a workflow are disclosed. Certain embodiments relate to determining the richness of a requester&#39;s requisition data. Certain embodiments relate to determining the richness of an interpreter&#39;s interpretation data that is related to the requisition data. The richness of the requisition data and the interpretation data can be compared to determine whether the interpretation data is deficient. If the interpretation data is deficient, the interpreter can be notified so as to increase the value of the interpretation data to the requester. The richness of the requisition data can also be used to determine whether the subject data set would benefit from group collaboration, rather than interpretation by a single interpreter. The disclosed systems and methods have applications including, but not limited to, training, performance analysis, process improvement, and data analysis and data mining in workflows.
&lt;P&gt;PROBLEM TO BE SOLVED: To provide an active ingredient highly safe in administration to a human body, and exhibiting excellent bioactive effects; and to provide a food containing the active ingredient.  &lt;P&gt;SOLUTION: The inhibitor of colon cancer contains a glucosylceramide fraction extracted from true fungi as the active ingredient. Preferably, the true fungi are selected from a yeast, a mold and a mushroom in the inhibitor of the colon cancer. The inhibitor of the colon cancer prevents the onset of the colon cancer. The food is obtained by formulating the inhibitor of the colon cancer.  &lt;P&gt;COPYRIGHT: (C)2005,JPO&amp;NCIPI
A solidified lotion is provided. The lotion includes a mixture of moisturizers and solidifying agents and forms a solid at room temperature. The lotion is manufactured into solid shapes which each include a single use quantity of lotion. The individual solid shapes are coated with a starch such as arrowroot powder. These individual shapes of solid lotion are sufficiently durable to not deform or stick to each other; allowing a large quantity of the solid lotion shapes to be packaged together without individual wrapping or packaging. During use, the lotion shapes melt when rubbed onto a person&#39;s skin and allow for quick absorption into the skin.
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a process for preparing a biodegradable, biocompatible microparticle.  &lt;P&gt;SOLUTION: The process comprises a step wherein a microparticle containing a biodegradable, biocompatible polymer matrix containing an active agent (e.g. a formulation or diagnostic agent) and an organic solvent is contacted with an aqueous solvent system, to reduce the content of the organic solvent in the microparticle to ≤2 wt% based on the weight of the microparticle, and the microparticle is recovered from the aqueous solvent system. Here, the aqueous solvent system (a) is kept at an somewhat elevated temperature (e.g. 25-40°C) for some time and/or (b) contains water and a water-miscible solvent against the above organic solvent.  &lt;P&gt;COPYRIGHT: (C)2006,JPO&amp;NCIPI
The utility model discloses a medicine plaster used to cure spontaneous perspiration for children, which comprises an adhesive layer with air holes. A film layer for insulating medicine, a medicine layer and a covering paper layer are provided on the adhesive layer. A cone-shaped protrusion whose size corresponds to that of children&#39;s bellybutton is pressed and covered by the medicine layer. The layer for insulating medicine has a shape of roundness and its diameter is larger than bottom of medicine layer. The covering paper layer has a size which corresponds to that of the adhesive layer and covers on the adhesive layer and the medicine layer. Compared with prior art, the utility model is characterized in reasonable design, simple structure, convenient fabrication and usage, as well as easy absorption and obvious curative effects, thereby is an ideal medicine plaster used for curing spontaneous perspiration of children and can be extensively applicable for clinic.
Various embodiments provide methods and systems for the biphasic iontophoretic transdermal delivery of therapeutic agents. An embodiment of a method for such delivery comprises positioning at least one electrode assembly in electrical communication with a patient&#39;s skin. The assembly includes a solution comprising a therapeutic agent which passively diffuses into the skin. A dose of agent is delivered from the assembly into the skin during a first period using a first current having a characteristic e.g., polarity and magnitude, to repel the agent out of the assembly. During a second period, a second current having a characteristic to attract the agent is used to retain the agent in the assembly such that delivery of agent into skin is minimized. A dose of agent may be delivered on demand by an input from the patient. Embodiments may be used for delivery of agents which cause adverse effects from unwanted passive diffusion.
PURPOSE:To obtain the subject inhibitor useful as a anticancer agent free from side effects, immunosuppressant, etc., by including a benzoylacrylamide having a specific structure and exhibiting extremely strong tyrosine kinase-inhibiting activity and action for suppressing proliferation of cancer cell as an active ingredient. CONSTITUTION:The objective inhibitor contains a benzoylacrylamide derivative of formula I (R&lt;1&gt; and R&lt;2&gt; are H, 1-5C alkyl, etc.; R&lt;3&gt; to R&lt;7&gt; are H, halogen, etc.) or its salt as an active ingredient. Furthermore, the compound of formula I is obtained by reacting, e.g. an acetophenone derivative of formula II with glyoxylic acid of the formula CHOCO2H in a solvent such as THF in the presence of a catalyst such as acetic acid at 20-150 deg.C for 30min to 5hr to afford a benzoylacrylic acid of formula III and then reacting the benzoylacrylic acid of formula III with amines of the formula R&lt;1&gt;R&lt;2&gt;NH in a solvent such as THF in the presence of a condensing agent such as phosphorus oxychloride.
PURPOSE:To provide a cosmetic compounded with a water-soluble peptide and/or amino acid produced by the hydrolysis of vegetable seed protein, capable of keeping fair skin by its high water-retainability and film-forming property and giving flexibility to the hair. CONSTITUTION:A vegetable seed having a protein content of &gt;=6wt% (e.g. wheat, soybean, cashew nut, etc.) is pulverized and hydrolyzed e.g. by acid decomposition, enzymatic decomposition, etc. The obtained slurry material is filtered to obtain clear filtrate. A concentrated liquid having a concentration of 20wt% and produced by the thermal concentration of the filtrate is added to a cosmetic in an amount of 0.5-5%, or a dried powder produced from the filtrate is added to a cosmetic at a rate of 0.1-10%. The softness and manageability of hair can be improved and the damage of hair with permanent wave lotion, etc., can be prevented by adding the concentrated liquid to a hair cosmetic such as hair rinse, hair cream, etc., in an amount of about 1-10%.
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a method for giving controlled stimulation to cells, promoting wound healing of the cells, and achieving healing of an aneurysm by organization and scar formation.  &lt;P&gt;SOLUTION: A method for producing an intravascular inflammatory response includes positioning a separable coil comprised at least in part of at least one biocompatible and absorbable polymer in a body lumen. The coil operates as polymer having biodegradability and biocompatibility to cause the controlled inflammatory response by giving stimulation to the cells. In the endovascular inflammatory response, an intravascular cellular manipulation and inflammatory response are elicited from implantation of the separable coil in a vascular compartment or any intraluminal location. Typically a catheter associated with the separable coil is used to dispose the coil into a selected body lumen. The biocompatible and absorbable polymer is thrombogenic.  &lt;P&gt;COPYRIGHT: (C)2004,JPO&amp;NCIPI
PURPOSE:To provide the titled remedy containing a calcium compound as an active component. CONSTITUTION:A remedy for hyperphosphatemia can be prepared by using a calcium compound [e.g. an inorganic acid salt such as CaCO3, CaCl2, etc., or an organic acid salt having an acid dissociation index (pKa) of &gt;=4 in water, e.g. calcium acetate, especially preferably precipitated calcium carbonate] as an active component. It can be administered in powdery form or tablet, capsule, granule, suspension, etc. The tablet or granule may be coated with a gastric or enteric dissolving coating to improve the takability. The dose should be properly adjusted to the symptom of the patient. Since the patient of hyperphosphatemia is frequently complicated with hypocalcemia, the administration of the calcium compound is advantageous in view of the supply of calcium, and furthermore, the agent has high safety. For example, the maximum dose of precipitated calcium carbonate is as high as &gt;=10g daily.
Intra-abdominal lesions, such as hemorrhage and inflammation/infection, often lead to pathological accumulations, posing serious challenges for critically ill patients. These lesions can rapidly induce intra-abdominal hypertension and organ damage, which may progress to hemorrhagic or septic shock, endangering patients\&#39; lives. Intra-abdominal hemorrhage, especially surgery-related hemorrhage, is difficult to detect early, and existing assessment methods like CT scans have limited applicability in critically ill patients. Intra-abdominal infections account for a high proportion of infections in critically ill patients, with concurrent sepsis or shock having high mortality rates. Despite advancements in critical care medicine, the mortality rate from intra-abdominal infections remains stubbornly high. Accurate assessment of the source and extent of infection is crucial for treatment, yet routine physical examinations have low sensitivity in critically ill patients, making imaging examinations the primary method. However, while abdominal CT is considered the gold standard, it is limited by insufficient dynamic monitoring and difficulties in patient transport. Bedside ultrasound plays a significant role in the monitoring of critically ill patients due to its portability, non-invasiveness, and real-time dynamic capabilities. It can assess sources of hemorrhage and infection, quantify the extent of lesions, and monitor hemodynamic changes. Therefore, this study aims to develop a comprehensive ultrasound assessment protocol that covers the peritoneal cavity and posterior peritoneal space. Through a prospective observational study, we aim to validate its sensitivity and specificity in diagnosing pathological accumulations such as intra-abdominal hemorrhage/infection and explore its correlation with patient clinical outcomes.
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a medicament inhibiting or preventing the formation of kidney stones by its binding to an oxalate.  &lt;P&gt;SOLUTION: Conditions such as kidney stones, which are characterized by undesired absorption of an oxalate from the intestinal tract, are conveniently treated using nontoxic salts of rare earth metal ions. A method is for controlling, preventing, or treating subjects who are at risk for or who exhibit symptoms of oxalate deposits in the kidneys, i.e., kidney stones, through the oral administration of rare earth salts, e.g. lanthanum salts, with high affinity oxalate binding properties. Preferred rare earth salts are those of yttrium, lanthanum and cerium.  &lt;P&gt;COPYRIGHT: (C)2009,JPO&amp;INPIT
A skin care delivery device is disclosed. The skin care delivery device includes a substrate containing a skin care composition. The skin care composition can comprise, for instance, any suitable lotion or other similar material. In accordance with the present disclosure, a backing is releasably engaged to one surface of the substrate. The backing facilitates folding and unfolding of the delivery device. Once applied to a user&#39;s skin, the backing can be peeled away and discarded.
503,642. Gonadotropic hormones. INSTITUT DE SEROTHERAPIE HEMO-. POIETIQUE SOC. ANON. Dec. 20, 1937, No. 35301. Convention date, Dec. 19, 1936. [Class 81 (i)] Gonadotropic hormones&#39; are obtained from the serum of pregnant mares by adding an equal volume of acidified alcohol to precipitate albuminous substances, removing the precipitate, and then adding a further quantity of alcohol to precipitate the hormones. According to an example sodium chloride is added together with the final quantity of alcohol. The hormopes may be further purified by dissolving the precipitate in dilute alkali solution, neutralization of the solution, addition of an equal volume of alcohol to precipitate impurities and addition of more alcohol to the clear solution to re-precipitate the hormones. These steps may be repeated. Water may replace the dilute alkali solution for extraction of the. hormones. The Specification as open to inspection under Sect. 91 refers also to a known process according to which acetone is added to the serum to precipitate the hormone together with albuminous substances, and the hormone is extracted from the precipitate by means of dilute alcohol. This subject-matter does not appear in the Specification as accepted.
A sustained release, orally administrable pharmaceutical tablet is prepared by substantially completely coating by spraying a granulation mixture comprising a &#34;high dosage&#34; medicament and a binding agent therefor with a sustained release lipid material resistant to disintegration and slowly dispersable in the gastro-intestinal tract to form coated granules which are thereafter tableted.  The lipid material may be sprayed as a solution in a volatile solvent and may be a wax, a fatty acid, alcohol or ester, many examples of which are given, including animal, vegetable and mineral waxes, esters of C12-31 fatty acids with C12-31 alcohols, C10-22 fatty acids, C10-22 fatty alcohols, mono-, di- and tri-glyceryl esters of C10-22 fatty acids and hydrogenated oils. Specified medicaments are those administered in 0.3 to 1 g. doses such as tranquilizers, e.g. chlorpromazine, diuretics, e.g. aminophylline, sedatives, e.g. secobarbital, antibiotics, e.g. tetracycline, vitamins, hematinics, antacids and analgesics, e.g. aspirin.
An electronic stethoscope (ES) is used to supply a given periodic cardiac murmur in each case via a digital-analog converter (AD) as a data sequence (DD) to a program-controlled computer (DC) which outputs diagnostic data (DP) about the cardiac murmur on an output unit (AG) by means of an analytical program. The cardiac murmur is to be classified quantitatively as regards preselectable reference cardiac murmurs without any further aids. Maxima-related period sections are selected from an enveloping function of the data sequence (DD), standardized in time and segmented, whereupon segment characteristics are formed and averaged for several period sections which are classified according to the appropriately processed reference characteristics of the reference cardiac murmurs stored in the reference memory (MM). The classification output is ordered according to relevance with regard to predetermined reference designations. The segment characteristics and reference characteristics can be archived in compact form on a data carrier (DT). This results in objective cardiovascular diagnosis even by auxiliary staff or trainees. &lt;IMAGE&gt;
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a medical administration system storing information on patients&#39; medicine dosages in an information storage medium and transmitting it to a medical institution.  &lt;P&gt;SOLUTION: This system comprises the information storage medium, a medication administration device, and a medical administration device connected to the medication administration device via a network. The information storage medium is provided with a storage means stored with ID information and medicine dosage information. The medication administration device is provided with a reading means reading information of the information storage medium, a timing means, a medicament dispensing means, a control means dispensing the medicament at a predetermined time based on the dosage information, a detecting means detecting the take-out of the medicament, a means of writing dispensed medicament information and time information taking out the medicament in the information storage medium, and means of transmitting the information stored in the information storage medium to the medical administration device via the network. The medical administration device is provided with patient information database and a register means registering the information received form the medication administration device linked with the ID information in the patient information database.  &lt;P&gt;COPYRIGHT: (C)2005,JPO&amp;NCIPI
PURPOSE:To obtain inorg. compd. fine particles which efficiently cuts near infrared rays and has transparency and such a decorating effect that the color tone of the particles changes depending on the change of the visual angle or the incident angle of light. CONSTITUTION:This inorg. compd. fine particle contains 60-100wt.% inorg. compd. and its surface has a group of thin chips having a projecting edge. These fine particles are produced, for example, by dissolving or dispersing zinc, monocarboxylic acid, and lactic acid in almedium comprising at least alcohol, and keeping the obtd. mixture at &gt;=100 deg.C to crystallize zinc in the mixture. These fine particles are mixed with a binder component to obtain a coating compsn., mixed with a resin to obtain a resin compsn. or a resin molded body, mixed with pulp to make paper, or added to a cosmetic material.
PROBLEM TO BE SOLVED: To obtain a capsule having good disintegrating properties. SOLUTION: This capsule comprises vitamin E, vitamin C, a processed garlic and a surfactant having &gt;11 hydrophile-lypophile balance(HLB) value. A sucrose glycerol fatty acid ester is preferred as the surfactant. Amounts of the ingredients formulated based on 1 pt.wt. of the vitamin E are 0.1-3 pts.wt. of the vitamin C, 0.1-1 pt.wt. of the processed garlic and 0.02-0.5 pt.wt. of the surfactant.
The invention comprises compounds of the general formula &lt;FORM:1008172/C2/1&gt; where R represents H, a halogen atom, or an alkyl group having 1-4 C atoms and their acid addition salts, and the preparation thereof by subjecting a compound of the general formula &lt;FORM:1008172/C2/2&gt; to cyclization whereby hydrogen halide is eliminated, which is advantageously effected by heating to temperatures above 200 DEG  C., preferably in the presence of a basic catalyst or copper powder. A high-boiling solvent, e.g. paraffin oil or decalin, may be present.  2 - Halo - 3 - (21 - aminobenzoyl) - aminopyridines of the second general formula above are prepared by reduction of the corresponding 21-nitro compound either catalytically or with nascent hydrogen.  2 - Halo - 3 - (21 - nitrobenzoyl) - aminopyridines are prepared by the reaction of a 2-halo-3-aminopyridine with a functional derivative of an appropriately substituted o-nitrobenzoic acid, preferably carried out in an inert solvent. A convenient functional derivative is the acid halide, when a hydrohalic acid-binding agent is preferably added.
PURPOSE:To provide an antibacterial film having excellent workability and suitable for the aseptic sealing and reinforcement of small utensil at the medical site, etc. CONSTITUTION:The objective antibacterial film is composed of a base film and an antibacterial layer formed on the surface of the base film. At least one dimension of the film is 5-100mm. The base film has relatively low strength and high drawability and exhibits self-adhesivity by drawing, releasability of self-bonded material and releasability from paper, glass, etc. For example, the film is a tape film of 25mm wide produced by applying p-chloroxylenol at a ratio of 5g/m&lt;2&gt; to one surface of a base film made of a petroleum wax, an elastomer or an ethylenic polymer. It can easily be drawn, applied and released by finger tip and prevents the contamination with microorganisms in the sealing and reinforcing work, etc.
The invention relates to a dendrobium nobile wine capable of nourishing yin and tonifying kidney and a preparation method thereof. The dendrobium wine for nourishing yin and tonifying kidney comprises the following raw materials in parts by weight: 10-12 parts of dendrobium, 15-18 parts of rhizoma polygonati, 30-36 parts of medlar, 500-600 parts of glutinous rice and 3.3-3.6 parts of distiller&#39;s yeast. The dendrobium officinale wine for nourishing yin and tonifying kidney takes dendrobium officinale as a monarch drug and is mainly used for strengthening yin and tonifying kidney; medlar is a ministerial drug, and dendrobium is used as an adjuvant drug for replenishing vital essence, treating nephropathy and nourishing kidney; rhizoma Polygonati is used as a guiding drug to enhance the spleen and stomach power and improve tiredness and hypodynamia. Has effects of nourishing yin, invigorating kidney, invigorating spleen, moistening lung, relieving fatigue, resisting oxidation, improving eyesight, and enhancing immunity. In addition, the added raw materials such as the medlar, the sealwort, the dendrobium and the like can improve the color and luster of the wine, so that the wine has bright deep red color and the organoleptic properties of the wine are improved. The preparation method of the dendrobium wine for nourishing yin and tonifying kidney has easily controlled process and is beneficial to large-scale production.
FIELD: medicine, surgery. SUBSTANCE: the present method deals with treating multiple costal fractures. Costal ends are covered along the perimeter with allotransplant to fix it with medicinal glue and special sutures by prefilling the defect between fractures with composite consisting of &#34;Sulfacrylate&#34; medicinal glue and acetone at 1:5 ratio and antibiotic powder with methyluracil. Moreover, allotransplant&#39;s sizes should exceed the sites of fractures being not less than 2 cm by length. EFFECT: higher efficiency of restoration. 3 cl